Group items matching

in title, tags, annotations or url

One-stop Continuing Education Hub for Nursing (CNA, LPN, RN, and APRN) CE/CNE Credits and Board Certification Courses. Find & Register on eMedEvents.

Parenting Children with Lyme Disease is organized by AchieveCE, this course is intended for Nurses.

Public Health is organized by Remote Care Education. this course has been approved with a maximum of 7 AMA PRA Category 1 Credits

IPV Assessment and Treatment Strategies are organized by AchieveCE, this course is intended for Nurses

In this blog, we will cover everything you need to know about breast surgery procedure in Thailand, from the initial consultation to post-operative care. We will provide you with valuable information about the different types of breast surgery procedures available, how to choose the right surgeon, and what to expect during recovery.

This CME/CE course on Cardiovascular Health in Postmenopausal Women explores data on cardiovascular disease in this demographic, covering incidence, impact, underlying causes, and associated risk factors.

Medical professionals often prescribe semaglutide to patients who have type 2 diabetes. Along with a balanced diet and regular exercise, it has also shown to be an incredibly efficient weight loss aid for patients. As the active ingredient in well-known brand-name drugs such as Wegovy, Ozempic, and Rybelsus, semaglutide is currently on everybody's lips. But what exactly is semaglutide? Does it really work for weight loss? We'll find an answer for you in this article, and explain the main benefits of using semaglutide for weight loss. What Is Semaglutide? A number of diabetic and weight loss medications, including Wegovy, Ozempic, and Rybelsus, have semaglutide as their active ingredient. This substance is a synthetic form of the hormone glucagon-like peptide-1 (GLP-1), that occurs naturally. Developed by the company Novo Nordisk, semaglutide was first approved by the FDA in 2017 as an injection for the treatment of adult type 2 diabetes (as part of the approval procedure for Ozempic). In 2019, the Food and Drug Administration approved a novel semaglutide form known as Rybelsus. Rybelsus was the first oral GLP-1 receptor agonist for the treatment of type 2 diabetes in the United States.

Recent NHS data sheds light on the evolving landscape of fit note certification, indicating a gradual expansion of roles beyond traditional medical practitioners to pharmacists and nurses. This uptake in numbers coincides with the Department of Work and Pensions's (DWP) call for evidence in relation to fit note reform which will remain open till 8 July 2024. According to figures published by NHS Digital, during the nine-month period from April 2023 to December 2023, pharmacists certified a significant number of fit notes. Approximately 1.4 per cent of fit notes of the 8 million were issued by pharmacists while the rest were issued by the GP surgeries reflecting the impact following legislative amendments in July 2022, which extended certification authority to pharmacists, nurses, occupational therapists, and physiotherapists. In June 2022, the Pharmacists' Defence Association (PDA) advised pharmacists not to sign fit notes where the required therapeutic, diagnostic, or examination skills lie outside their scope of competence. The association remarked that healthcare professionals needed mandatory training under the Health Education England before they are fit to issue fitness notes to the public.

Elevate your expertise in Pediatric Medicine and Internal Medicine with our Comprehensive CME Courses Bundle.

Orthodontics Continuing Education Course is organized by OHI-S, Dentistry CE course has been approved with a maximum of 3.5 CPD Credits.

Anterior Aesthetics: The Complete Composite Guide is organized by OHI-S.

Using Precision Medicine to Address Health Disparities is organized by eMedEvents Corporation. Efforts to solve, and overcome health disparities have yielded modest changes.

Primary Care: Emergency Medicine Update is organized by AMS, Inc. and will be held from Mar 04 - 07, 2024, in Florida, USA. This Conference is intended for Emergency Medicine Physicians and Nurses.

People in the UK have a high level of trust in pharmacies and many are keen on seeing the Pharmacy First initiative expanded, according to the 2024 STADA Health Report published today (24 June). The 10th annual health report by global healthcare leader STADA Arzneimittel AG, the parent company of Thornton & Ross, involved a survey of over 46,000 respondents across 23 countries, including 2,000 participants from the UK. The UK data showed an overwhelming trust in UK pharmacies, with 94 per cent of those surveyed (more than nine out of 10 Brits) saying they have only ever had good advice from a pharmacist. The report also indicated a strong desire for the Pharmacy First scheme to be expanded, with 44 per cent of respondents advocating for an increase in pharmacists' scope of responsibilities to support doctors.

Elevate your professional journey with eMedEvents Prime. Access secure document storage, CME tracking, personalized course recommendations, multi-state compliance management, and exclusive discounts. Start your 30-day free trial today! Elevate Your Professional Journey with eMedEvents Prime Subscription - Exclusively for Healthcare Professionals